The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer

Author:

Zohny Samir F.12,Baothman Othman A.1,El-Shinawi Mohamed3,Al-Malki Abdulrahman L.1,Zamzami Mazin A.1,Choudhry Hani1

Affiliation:

1. Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

2. Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt

3. General Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference44 articles.

1. Cdks, cyclins and CKIs: Roles beyond cell cycle regulation;Lim;Development,2013

2. Ubiquitylation and proteasomal degradation of the p21^{Cip1}, p27^{Kip1} and p57^{Kip2} CDK inhibitors;Lu;Cell Cycle,2010

3. Gomez V. and Hergovich A., Cell-cycle control and DNA-damage signaling, in: Genome Stability from Virus to Human Application (Translational Epigenetics Series), Kovalchuk I. and Kovalchuk O., eds, Chapter 14, 1^{ed}., Academic Press, London, (2016); pp. 227-242.

4. WAF1, a potential mediator of p53 tumor suppression;El-Deiry;Cell,1993

5. P21 is a universal inhibitor of cyclin kinases;Xiong;Nature,1993

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China;Frontiers in Genetics;2023-11-09

2. Prognostic Significance of P21 Protein in Breast Cancer;Experimental and Applied Biomedical Research (EABR);2023-05-27

3. Cell Cycle Arrest: An Impending Therapeutic Strategy to Curb Cancer;Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models;2020

4. Significant function and research progress of biomarkers in gastric cancer (Review);Oncology Letters;2019-11-11

5. A TFAP2C Gene Signature is Predictive of Outcome in HER2-positive Breast Cancer;Molecular Cancer Research;2019-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3